SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (1259)8/28/2002 11:46:24 AM
From: Sultan  Read Replies (1) | Respond to of 1321
 
Reuters Company News

EU grants wider approval for Novartis' Visudyne
Wednesday August 28, 11:23 am ET

ZURICH, Aug 28 (Reuters) - The European Union has granted wider approval for eye-care product Visudyne, which treats complications of an illness that is a leading cause of blindness in older patients, Novartis (NOVZn.VX) said on Wednesday.

biz.yahoo.com